Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

HeartWare, Inc. manufactures electro medical and electrotherapeutic apparatus. The company develops implantable circulatory assist devices, which are used in treating patients with congestive heart failure problems. The company was established in 2003 and is headquartered in Miramar, FL

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Abiomed is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufacture and market products that is designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The Company's products are used in the cardiac catheterization lab (cath lab) by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures.

Cardiac Pacemakers, Inc.(CPI), doing business as Guidant Cardiac Rhythm Management, manufactured implantable cardiac rhythm management devices, such as pacemakers and defibrillators. It also sold insulin pumps controlled by microprocessors and various equipments to regulate heart rhythm. In addition, Cardiac Pacemakers, Inc. developed therapies for the treatment of irregular heartbeats. The company was founded in 1971 and is based in St. Paul, Minnesota. Cardiac Pacemakers, Inc. operates as a subsidiary of Boston Scientific Corporation.

MITRICARES aims to develop and market an implantable medical device for percutaneous treatment of tricuspid valves failed. The young company has already realized a first prototype successfully tested several times on the big animal. This new system would address a major public health problem, tricuspid insufficiency, which affects 4 million people in Europe and the USA, with a poor prognosis in the short term.

FineHeart SA manufactures medical devices for cardiovascular space. It offers wirelessly powered and fully-implantable mechanical circulatory support device. The company was founded by St��phane Garrigue and Philippe Ritter on January 13, 2010 and is headquartered in Pessac, France.

Boston Scientific Scimed, Inc. develops, manufactures, and markets medical devices used principally to treat cardiovascular disease.

Jiangsu Zhenyi Medical Technology Co., Ltd., established on 2019-07-15, Business scope includes research and development of medical devices,Production,Sales;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

BioVentrix, Inc. engages in development of medical devices. It offers Less Invasive Ventricular Enhancement, or the LIVE therapy, which uses the Revivent TC transcatheter ventricular enhancement system to exclude scar tissue on the left ventricle that has occurred from a heart attack. The company was founded by Arthur A. Bertolero and Lon S. Annest in 2003 and is headquartered in San Ramon, CA.

Medtronic Vascular designs and develops technologies for coronary, peripheral, and neurovascular indications. The company’s products include S7 Zipper MX Coronary Stent System, Clo-Sur PAD Nonwoven Hydrophilic Wound Dressing, Launcher Coronary Guide Catheter, and Stormer Over-the-Wire Balloon Dilatation Catheter. The company also offers Bridge Assurant Balloon-Expandable Stent Delivery System, GuardWire Plus Temporary Occlusion and Aspiration System, and S660 Coronary Stent. Medtronic Vascular was incorporated in 1991 and is based in Santa Rosa, California. As of January 29, 1999, Medtronic Vascular operates as a subsidiary of Medtronic.

Yuanshen (Shenzhen) Medical Devices Co., Ltd., established on 2021-09-26, Business scope includes general business items:Other technical promotion services;Sales of Class I Medical Devices;Medical Research and Experimental Development;Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology intermediary service.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:3Dprint service;Sales of Class II Medical Devices;Class III medical device business;Production of Class I Medical Devices;Production of Class II Medical Devices;Production of Class III Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Japan Lifeline Co., Ltd. engages in the import, development, production, and distribution of medical devices. It operates through the following divisions: Cardiac Rhythm Management, Electrophysiology and Ablation, Cadiovascular and Vascular Surgery, and Transvascular Intervention. The Cardiac Rhythm Management division provides implantable devices to treat arrhythmias. The Electrophysiology and Ablation division offers disposable catheter devices with electrodes for the diagnosis and treatment of arrhythmias. The Cadiovascular and Vascular Surgery division handles vascular grafts to treat blood vessels. The Transvascular Intervention division deals with devices for intravascular treatment of cardiac infarction, arterial occlusions of the lower extremities, and congenital cardiac diseases. The company was founded by Keisuke Suzuki and Takeshi Masumoto on February 6, 1981 and is headquartered in Tokyo, Japan.

Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. They help people with debilitating and complex conditions that are often difficult to diagnose and treat. They are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, they also established ourselves as a leader in the field of multiple sclerosis. In 2016, their focus expanded to include Sanofi’s programs in oncology and immunology. Their approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, they rapidly grew to become one of the world’s leading biotechnology companies, recognized for their pioneering development of treatments for rare genetic disorders and their innovative contributions to medical science and biomanufacturing.

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. engages in the manufacture, sale, research and development of household products and medical equipment. It also develops, manufactures, markets, and sells electro-medical equipment in the patient monitoring, laboratory instrument, and medical ultrasound fields. The company was founded by Hang Xu on January 25, 1991 and is headquartered in Shenzhen, China.

NovoCure GmbH, a subsidiary of NovoCure Ltd., is a company headquartered in Munich, Germany, that develops proprietary therapy. Wilhelmus C. M. Groenhuysen and Asaf Danziger are the current co-CEOs of the firm.

Cardiovalve is a medical device company developing a transfemoral mitral valve replacement system. The flagship Cardiovalve system is the first one designed to replace the mitral valve using a transfemoral system. It is designed from the bottom up for transfemoral/transseptal delivery with femoral venous access. Cardivalve approach offers significant benefits, including a short profile for minimal protrusion to the left ventricle, minimizing interference in the cardiac blood flow and increased safety. It is currently evaluating the safety and performance of its system in clinical studies and it will seek EU and US approval.

Suzhou Xinqing Medical Technology Co., Ltd. was founded in 2017 by Dr. Xu Bozhen, a special expert of the National Youth Thousand People Program and a special professor of Suzhou University. He is a high-tech enterprise with the main goal of developing the world's leading in vitro short-term ventricular assist device (in vitro artificial heart). . The core members of the company's entrepreneurial team are the world's top artificial heart engineering technology experts. With years of experience in overseas artificial heart research and development and productization, the company has developed a domestically produced artificial heart with independent intellectual property rights.